Back to investors
SOLEUS CAPITAL MANAGEMENT, L.P.
SOLEUS CAPITAL MANAGEMENT, L.P.
Latest filing: 2026-06-30
SOLEUS CAPITAL MANAGEMENT, L.P. runs SOLEUS CAPITAL MANAGEMENT, L.P. and currently holds 97 stock positions, which is fewer than the average of 230 among the investors we track. The portfolio is valued at approximately $2.90B. Their top holdings are KRYS, CELC, TGTX, PODD, NVCR. The top five represent 34.4% of reported portfolio weight. SOLEUS CAPITAL MANAGEMENT, L.P. ranks #N/A out of 1000 investors tracked by Alpha Score. In the most recent quarter, SOLEUS CAPITAL MANAGEMENT, L.P. initiated 11 new positions. They added to 18 existing positions. They trimmed 36 positions. Their current best-performing preview position is TWST with returns of +116.50%.
Sign in to enable email alerts for this investor.
Showper page
97 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 KRYS KRYSTAL BIOTECH INC | 12.03% | $172.03 | $346.58 | +101.46% | Trimmed -18.54% |
 CELC CELCUITY INC | 6.14% | $58.15 | $93.53 | +60.84% | Added +32.70% |
 TGTX TG THERAPEUTICS INC | 5.54% | $26.56 | $54.26 | +104.29% | Trimmed -27.34% |
 PODD INSULET CORP | 5.50% | $193.77 | $148.16 | -23.54% | Added +86.49% |
 NVCR NOVOCURE LTD | 5.18% | $18.16 | $17.10 | -5.84% | Trimmed -5.52% |
 UTHR UNITED THERAPEUTICS CORP DEL | 4.21% | $494.59 | $513.12 | +3.75% | Added +20.51% |
 INSP INSPIRE MED SYS INC | 2.97% | $51.73 | $62.44 | +20.70% | Added +235.14% |
 RIGL RIGEL PHARMACEUTICALS INC | 2.49% | $38.96 | $45.89 | +17.79% | Added +18335.04% |
 ANIP ANI PHARMACEUTICALS INC | 2.48% | $81.50 | $75.35 | -7.55% | Added +5.79% |
 BBNX BETA BIONICS INC | 2.37% | $11.55 | $19.05 | +64.94% | Added +0.90% |
Showing 1-10 of 97